investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
The role of epigenetic heterogeneity in CLL evolution
Dan Landau
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Dan Landau
Dana-Farber Cancer Institute
Boston, United States
Related projects
Derek B. Sant'Angelo
Control of cytokine production by human NK cells
Leukaemia
Soheil Meshinchi
Biology and Prognostic Implications of FLT3 Mutations in AML
Leukaemia
Alan Rein
Retrovirus Assembly and Maturation
Leukaemia
Pathology
Hematology and hematologic malignancies
Craig B Thompson
Role of IDH Mutations in Acute Myeloid Malignancies
Leukaemia
Charalampos Kalodimos
Mechanisms of autoinhibition and activation of the Abl kinase
Leukaemia
Scott H Kaufmann
Regulation of Death Ligand-Induced Killing
Leukaemia
Pathology
Hematology and hematologic malignancies
Kevin A Goncalves
Role of Angiogenin in Hematopoietic Stem Cell Quiescence and Self-renewal
Leukaemia
Pathology
Richard A Flavell
Understanding Hemotopoietic Neoplasias using Humanized Mice
Leukaemia
Pathology
Hematology and hematologic malignancies
Ross L Levine
Role of TET2 mutations in malignant transformation and acute myeloid leukemia
Leukaemia